Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C015001 |
arsenite |
arsenite results in decreased expression of C1QTNF6 mRNA | decreases expression | 19716837
|
C015001 |
arsenite |
arsenite results in increased methylation of C1QTNF6 promoter | increases methylation | 19716837
|
C447119 |
bazedoxifene acetate |
bazedoxifene acetate results in decreased expression of C1QTNF6 mRNA | decreases expression | 19914376
|
D002104 |
Cadmium |
Cadmium results in decreased expression of C1QTNF6 mRNA | decreases expression | 19716837
|
D002104 |
Cadmium |
Cadmium results in increased methylation of C1QTNF6 promoter | increases methylation | 19716837
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of C1QTNF6 promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
C014347 |
decitabine |
decitabine inhibits the reaction [sodium arsenite affects the methylation of C1QTNF6 promoter] | affects methylation|decreases reaction | 18448484
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of C1QTNF6 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of C1QTNF6 mRNA | increases expression | 17942748
|
D015735 |
Mifepristone |
Mifepristone results in increased expression of C1QTNF6 mRNA | increases expression | 17584828
|
C406082 |
monomethylarsonous acid |
[monomethylarsonous acid affects the acetylation of HIST3H3 protein] which affects the methylation of C1QTNF6 promoter | affects acetylation|affects methylation | 18448484
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in decreased expression of C1QTNF6 mRNA | decreases expression | 18448484 19716837
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in increased methylation of C1QTNF6 promoter | increases methylation | 19716837
|
C017947 |
sodium arsenite |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of C1QTNF6 promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
C017947 |
sodium arsenite |
decitabine inhibits the reaction [sodium arsenite affects the methylation of C1QTNF6 promoter] | affects methylation|decreases reaction | 18448484
|
C017947 |
sodium arsenite |
[sodium arsenite affects the acetylation of HIST3H3 protein] which affects the methylation of C1QTNF6 promoter | affects acetylation|affects methylation | 18448484
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of C1QTNF6 mRNA | decreases expression | 18448484
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of C1QTNF6 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of C1QTNF6 mRNA | increases expression | 17942748
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] inhibits the reaction [sodium arsenite affects the methylation of C1QTNF6 promoter] | affects cotreatment|affects methylation|decreases reaction | 18448484
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.76 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.04 | 15322242 14514962 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.16 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.84 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.57 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.92 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.12 | 16712894 17306315 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.64 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.74 | 15885639 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.72 | 15687053 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.18 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.87 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.87 | 17893378 17440819 18815881 16873071 18855134 19288272 19221464 15565566 19115204 20005174 18629630 18425577 19011961 17261762 16202921 19200415 19142967 20544844 19084267 15668708 19189212 17049068 19189210 21152245 19059307 19487384 18997820 20859285 11161223 19410462 19244106 19289846 18821012 21138602 18351453 18984771 19066611 20390343 16818667 19155303 19103187 16273361 17242785 20135344 20065188 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.68 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.12 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.12 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.92 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.92 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.75 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
12.04 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
12.04 | 19716837 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
12.04 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.98 | 11677210 16105132 17333356 16919318 17110522 15861022 17681005 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 15668235 16354765 15340226 12621046 8697196 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
4.07 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
4.07 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 15322242 10048152 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.54 | 19031437 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
marker/mechanism |
|
| 18978792 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.60 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.57 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.51 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.49 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.49 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
14.77 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
14.77 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.13 | 20544844 17893378 19155303 16202921 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
9.59 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.59 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
14.01 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
14.01 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
14.01 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.31 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.72 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.38 | 19069698 |
MESH:D005355 |
Fibrosis |
|
arsenite |
9.41 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.41 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.87 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
3.92 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.58 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.40 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.07 | 12621046 15340226 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.27 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 18606429 15340226 16959395 8697196 16354765 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.95 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.98 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.61 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
11.77 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.77 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.77 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.11 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.11 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
6.70 | 16322080 16226777 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.70 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
3.16 | 18625569 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.13 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.14 | 17236224 18454857 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.35 | 18460780 18206229 17679729 18704418 19010910 19387464 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.35 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.68 | 18055864 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.25 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.49 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.32 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.32 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.69 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.69 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.69 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.26 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
4.98 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.98 | 17077188 16712894 15276417 19931552 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.98 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.98 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.52 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.95 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.71 | 11731420 19196722 14580682 19196723 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.76 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
7.54 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.54 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
7.54 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
7.54 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.38 | 15990972 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.99 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
7.99 | 18172295 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.46 | 19010910 19157545 18608210 16882708 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.59 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.55 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.43 | 19470736 17925555 19116145 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.43 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.84 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.22 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.61 | 15738583 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.23 | 12854658 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.72 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
11.72 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
11.72 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
11.72 | 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.83 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
5.83 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.84 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.58 | 15687053 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11118676 11222880 11399792 11896295 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
13.02 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
13.02 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.13 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.13 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.13 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.13 | 19789329 18798265 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.51 | 16919318 15861022 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.55 | 19155313 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.41 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.79 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.79 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.30 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.30 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.23 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.90 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.77 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.28 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.43 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
12.42 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
12.42 | 20375083 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
12.42 | 16712894 11723127 17306315 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
12.42 | 16712894 17572228 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.90 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.46 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.13 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.62 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.68 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |